Chronic lymohocytic leukaemia: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

Erstveröffentlichung
2021Authors
Eichhorst, B.
Robak, T.
Montserrat, E.
Ghia, P.
Niemann, C. U.
Wissenschaftlicher Artikel
Published in
Annals of Oncology ; 32 (2021), 1. - S. 23-33. - ISSN 0923-7534. - eISSN 1569-8041
Link to publication
https://dx.doi.org/10.1016/j.annonc.2020.09.019Institutions
UKU. Institut für Experimentelle TumorforschungSubject headings
[Free subject headings]: chronic lymphocytic leukaemia | prognostic factors | individualised therapy | B-cell receptor inhibitors | BCL2 inhibitor | targeted treatment | CHRONIC LYMPHOCYTIC-LEUKEMIA | MINIMAL RESIDUAL DISEASE | OPEN-LABEL | CELL TRANSPLANTATION | PROGNOSTIC INDEX | CD38 EXPRESSION | TP53 MUTATION | CLL-IPI | RITUXIMAB | IBRUTINIB[DDC subject group]: DDC 610 / Medicine & health